This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Traditionally the pharma industry relied on the volume of prescriptions made. A survey conducted by Cegedim revealed that KeyAccountManagement (KAM) was the technique that procured the best results for market access strategies. The product was then targeted to specific physicians and dispensed to pharmacies.
Traditionally the pharma industry relied on the volume of prescriptions made. A survey conducted by Cegedim revealed that KeyAccountManagement (KAM) was the technique that procured the best results for market access strategies. The product was then targeted to specific physicians and dispensed to pharmacies.
Companies that adopt this blended model will be able to recognise performance gaps earlier and, for the first time, align incentives across the entire commercial ecosystem, including sales reps, keyaccountmanagers, and medical science liaisons.”. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.
A lot of organizations that may have a sales model don’t probably follow the prescription that we deliver or the method that we deliver to them, which is why they contract us. We typically work with advanced consultative skills, which are different skillsets. When do companies realize they need someone like you?
Takeda Connect provides oncologists with information about their KeyAccountManager and Medical Science Liaison, alongside direct access at the click of a button. Beyond personalising content, creating a tailored channel experience is also vitally important. While field force teams in areas of the world such as the U.S.,
Pharma has always been highly restrictive in terms of the different tools you can use to engage, educate and inform about prescription medicines. Prescription medicine companies simply have fewer ways of reaching audiences at scale compared to nearly any other industry. Challenge 1: Limited set of marketing and sales tools.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content